Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis - Mikhael, J R; Schuster, S R; Jimenez-Zepeda, V H (Blood, 2012)
, et al.